FDA Approved: Yes (First approved December 5, 2017) Brand name: Ozempic Generic name: semaglutide Dosage form: Injection and Tablets Company: Novo Nordisk Treatment for: Type 2 Diabetes, Cardiovascular Risk Reduction, Chronic Kidney Disease Add Drugs.com on Google Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) analog for the treatment type 2 diabetes, and to reduce the risk of major cardiovascular events and worsening kidney disease in patients with type 2 diabetes
Mol Biol Cell 30: 10981107, 2019
This gives us a clue that there might be a connection, but randomized controlled studies would be the best way to discover whether semaglutide can actually help people quit smoking. The side effects of semaglutide are well understood and include: abdominal pain constipation diarrhea nausea and vomiting These could deter some people from using this drug to quit smoking
These may play a key role in the high increased half life of the Semaglutide-GLP-1R complex (165+ hours, compared to the ~13 hours in the case of Liraglutide)
The timeline of weight reduction is influenced by various factors, including treatment duration and patient-specific characteristics